29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
Every facet of the construction industry has been impacted by COVID-19. Commercial and residential ...
Read More >
“What did I do wrong?” and “Am I doing this correctly” are frequent questions from clients regar...
Read More >
Effective August 26, 2019, the Illinois Open Meetings Act has been amended, expanding the closed mee...
Read More >
USMCA? A-OK, Says Senate. The United States–Mexico–Canada Agreement (USMCA) has been in the Limeli...
Read More >
On July 4, 1776, the thirteen American colonies formally severed their ties to the English throne an...
Read More >
Welcome to the Great Women in Compliance Podcast, co-hosted by Lisa Fine and Mary Shirley. In this e...
Read More >